NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
170 hedge funds and large institutions have $1.61B invested in NxStage Medical Inc. in 2016 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 45 increasing their positions, 72 reducing their positions, and 17 closing their positions.
27,700% more call options, than puts
Call options by funds: $834K | Put options by funds: $3K
94% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 17
9% more funds holding
Funds holding: 156 → 170 (+14)
0% more capital invested
Capital invested by funds: $1.6B → $1.61B (+$5.77M)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
38% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 72
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pennant Capital Management
Summit,
New Jersey
|
+$37.8M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$14M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
+$7.42M |
| 4 |
PA
Perceptive Advisors
New York
|
+$6.39M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$5.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$47.6M |
| 2 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$17.5M |
| 3 |
Millennium Management
New York
|
-$13.8M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$11.5M |
| 5 |
Goldman Sachs
New York
|
-$11.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BJL
176
Brighton Jones LLC
Seattle,
Washington
| – | -$803K | -32,150 | Closed |
|
|
AG
177
Algert Global
San Francisco,
California
| – | -$638K | -25,514 | Closed |
|
|
DC
178
Deere & Company
Moline,
Illinois
| – | -$515K | -20,605 | Closed |
|
|
VIA
179
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$511K | -20,435 | Closed |
|
|
TI
180
Trexquant Investment
Stamford,
Connecticut
| – | -$436K | -17,455 | Closed |
|
181
Bessemer Group
Woodbridge,
New Jersey
| – | -$420K | -16,800 | Closed |
|
|
MAM
182
Martingale Asset Management
Boston,
Massachusetts
| – | -$420K | -16,800 | Closed |
|
|
AWE
183
Avidian Wealth Enterprises
Houston,
Texas
| – | -$344K | -13,774 | Closed |
|
184
Wellington Management Group
Boston,
Massachusetts
| – | -$339K | -13,547 | Closed |
|
185
Squarepoint
New York
| – | -$230K | -9,194 | Closed |
|
|
FMT
186
First Mercantile Trust
Cordova,
Tennessee
| – | -$224K | -8,961 | Closed |
|
NXTM Hedge Fund Activity: Q4 2016 in Review
170 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q4 2016, worth a combined $1.61B — up 0.36% from $1.6B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new NXTM positions and 17 closed out — a net gain of 16 holders — while 45 added to existing stakes and 72 trimmed.
The largest buyer was Pennant Capital Management, adding an estimated $37.8M. The largest seller was Fidelity Investments, cutting an estimated $47.6M.
- 170 institutional investors held NxStage Medical Inc. (NXTM) as of Q4 2016, up from 156 in Q3 2016.
- Funds reported $1.61B of NxStage Medical Inc. stock for Q4 2016, up 0.36% quarter-over-quarter.
- 33 funds opened new NxStage Medical Inc. positions in Q4 2016 and 17 closed out, a net change of +16 holders.
- The largest NxStage Medical Inc. buyer in Q4 2016 was Pennant Capital Management, an estimated $37.8M added.
- The largest NxStage Medical Inc. seller in Q4 2016 was Fidelity Investments, an estimated $47.6M sold.
Based on aggregated 13F filings for Q4 2016.